Friday, December 15, 2006

Gary Crandall, CEO



PRWeb - On the FDA Panel Ruling Approving Vagus Nerve Implant for Depression Treatment A seriously flawed research study, unknown, yet predictable consequences of the use of the device and a threat to the existence of Psychiatry itself, head the reasons for
Source: www.prweb.com

At the Helm:
Reuters - Before the Icahn news, Cyberonics' shares had lost nearly half their value since the start of the year as the company reduced sales projections for the depression treatment, which was launched in August 2005. The Houston-based company is also being
Source: today.reuters.com

Antidepressants Reduce Suicide in Children Despite FDA Warning
HealthCentral.com - Researchers are concerned children may not get the depression treatment they need. Dr. Gibbons said, "There's concern there is a lot of untreated depression in children and the potential for increases in the rates of suicide." The black-box warning
Source: www.healthcentral.com

Micro-Cap Spotlight: Clinical Data Inc.
Stockhouse Canada - We haven't even yet touched the subject of "Vilazodone," Clinical Data's experimental depression treatment, which is approaching Phase III pivotal trials, with almost 200 of 400 patients already chosen. Vilazodone tablets are already being
Source: www.stockhouse.ca


Click here for more information about elderly depression elderly depression